Clinical Trial Update: Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma [Phase 1, Phase 2]

View source ↗

Summary

Orellanine is being studied in metastatic renal cell carcinoma (clear-cell and papillary) in Phase 1/Phase 2, with patient recruitment currently ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Orellanine

Snippet

Sponsor: Oncorena AB | Conditions: Carcinoma, Renal Cell | Phase 1, Phase 2 | Status: RECRUITING